It is a healthcare private limited company based in Bangalore, Karnataka, India, established in 2006.
2006 | Bangalore, Karnataka, India | ActiveHoogar Pharmaceuticals Private Limited, a active private limited company, was established on 11 July 2006 in Bangalore, Karnataka, India. Engaging in alternative & holistic medicine within the healthcare sector, it holds CIN: U52311KA2006PTC039922. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Jyothi Basavaraj Hoogar (Director), Naveen Basavaraj Hoogar (Director). Past directors included Shridhar Shivasharanappa Hoogar, Basavaraj Shivasharanappa Hoogar, Shivanand Shivasharanappa. It holds ₹1.40 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at No 649, 6Th Main, 5Th Cross, Vijayanagar,, Bangalore, Karnataka, 560040.
U52311KA2006PTC039922
039922
11 July 2006
₹5.00 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Hoogar Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jyothi Basavaraj Hoogar | Director | 11 Jul 2006 | Current |
| Naveen Basavaraj Hoogar | Director | 12 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Dec 2015 | Past |
| Pramod Abcsdd | Director | 08 May 2021 | Past |
| Pramod Abcsdd | Director | 04 Dec 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hoogar Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 43.01% decrease. The company also saw a substantial fall in profitability, with a 49.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 268.05%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Hoogar Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹14,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Oct 2019 | Karnataka State Financial Corporation | ₹1.00 Cr | Open |
| 02 May 2011 | Karnataka State Financial Corporation | ₹4.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Hoogar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hoogar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hoogar Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Hoogar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Hoogar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore. was recorded as a recent event.
Progress on Naveen Basavaraj Hoogar was appointed as a Director was appointed as a Director on 12 Aug 2021 & has been associated with this company since 4 years 4 months . was documented.
A charge with Karnataka State Financial Corporation amounted to Rs. 10.00 M with Charge ID 100297229 was registered on 25 Oct 2019. was recorded as a recent event.
Progress on A charge with Karnataka State Financial Corporation amounted to Rs. 4.00 M with Charge ID 10284523 was registered on 02 May 2011. was documented.
The activity Jyothi Basavaraj Hoogar was appointed as a Director was appointed as a Director on 11 Jul 2006 & has been associated with this company since 19 years 5 months . was completed.
The CIN of Hoogar Pharmaceuticals Private Limited is U52311KA2006PTC039922.
Hoogar Pharmaceuticals Private Limited is headquartered at No 649, 6Th Main, 5Th Cross, Vijayanagar,, Bangalore, Karnataka, 560040.
Hoogar Pharmaceuticals Private Limited was incorporated on 11 July 2006.
The current directors of Hoogar Pharmaceuticals Private Limited are
The primary industry of Hoogar Pharmaceuticals Private Limited is Healthcare.
Hoogar Pharmaceuticals Private Limited is unlisted.
The authorized capital of Hoogar Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Hoogar Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX